Allogeneic stem cell transplantation

Allogeneic stem cell transplantation has been studied in 5 papers since 2016: 5 observational studies in people. The newest paper, Sep 4, 2021: “Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot study”.

Intervention

5 papers study it1 findingUpdated

See all 5 papers on allogeneic stem cell transplantation

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“allogeneic transplant recipients (1.9-fold increase, p=0.0004)”
Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell AgingEBioMedicine2016doi:10.1016/j.ebiom.2016.08.029
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Cancer Institute and 2 more
  • Humans5

What did studies of allogeneic stem cell transplantation find?

1

Studies of allogeneic stem cell transplantation measured one outcome, p16INK4a.

p16INK4a

upin humans1

1 study
  1. Allogeneic stem cell transplantation is linked with higher p16INK4a in humans (1.9-fold increase, p=0.0004).

    HumansT-cells6 months

More on p16INK4a

Latest